These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25383821)

  • 1. Bilateral nanophthalmic uveal effusion syndrome: clinical presentation and surgical management.
    Abell RG; Kerr NM; Vote BJ
    Retin Cases Brief Rep; 2013; 7(4):386-90. PubMed ID: 25383821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two cases of uveal effusion syndrome.
    Lee JH; Choi JY; Kim SS
    Korean J Ophthalmol; 2006 Jun; 20(2):124-7. PubMed ID: 16892650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unusual non-nanophthalmic uveal effusion syndrome with histologically normal scleral architecture: a case report.
    Kaewsangthong K; Thoongsuwan S; Uiprasertkul M; Phasukkijwatana N
    BMC Ophthalmol; 2020 Jul; 20(1):311. PubMed ID: 32727414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial Nanophthalmos Presenting with Spontaneous Uveal Effusion Syndrome.
    Bansal R; Menia NK; Gupta A
    Ocul Immunol Inflamm; 2020; 28(2):191-193. PubMed ID: 30556758
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparing the Results of Vitrectomy and Sclerectomy in a Patient with Nanophthalmic Uveal Effusion Syndrome.
    Popov I; Popova V; Krasnik V
    Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33572746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerotomy in uveal effusion syndrome.
    Faulborn J; Kölli H
    Retina; 1999; 19(6):504-7. PubMed ID: 10606449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid resolution of severe exudation in uveal effusion syndrome with anti-vascular endothelial growth factor alone in a case of bilateral nanophthalmos: a case report.
    Song L; Dong F; Yi C
    J Med Case Rep; 2021 Oct; 15(1):515. PubMed ID: 34663453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive circumferential partial-thickness sclerectomy in eyes with extreme nanophthalmos and spontaneous uveal effusion.
    Mansour A; Stewart MW; Shields CL; Hamam R; Abdul Fattah M; Sheheitli H; Mehanna CJ; Yassine S; Chahine H; Keaik M; Maalouf F; Jaroudi M
    Br J Ophthalmol; 2019 Dec; 103(12):1862-1867. PubMed ID: 30877130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uveal effusion syndrome: clinical features, surgical treatment, histologic examination of the sclera, and pathophysiology.
    Uyama M; Takahashi K; Kozaki J; Tagami N; Takada Y; Ohkuma H; Matsunaga H; Kimoto T; Nishimura T
    Ophthalmology; 2000 Mar; 107(3):441-9. PubMed ID: 10711879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution of serous retinal detachment following partial sclerectomy with mitomycin C in nanophthalmos.
    Venkatesh P; Majumdar SS; Kakkar A; Singh S; Gogia V; Garg S
    Ophthalmic Surg Lasers Imaging Retina; 2013; 44(3):287-9. PubMed ID: 23676234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histological observations on the sclera in uveal effusion].
    Tagami N; Uyama M; Yamada K; Kosaki J; Ohkuma H; Tomoda T
    Nippon Ganka Gakkai Zasshi; 1993 Feb; 97(2):268-74. PubMed ID: 8475840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanophthalmic uveal effusion managed with scleral windows and topical mitomycin-C.
    Akduman L; Adelberg DA; Del Priore LV
    Ophthalmic Surg Lasers; 1997 Apr; 28(4):325-7. PubMed ID: 9101574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Uveal effusion syndrome in nanophthalmic eye after trabeculectomy].
    Bluwol E; Nordmann JP
    J Fr Ophtalmol; 2007 May; 30(5):e13. PubMed ID: 17568336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quadrantic vortex vein decompression with subretinal fluid drainage for manangement of Nanophthalmic choroidal effusions- a review of literature and case series.
    Khatri A; Singh S; Joshi K; Kharel M
    BMC Ophthalmol; 2019 Oct; 19(1):210. PubMed ID: 31651283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pathologic studies on idiopathic uveal effusion.
    Weng N; Hu W; Sun X; Li L; Fu S
    Zhonghua Yan Ke Za Zhi; 1995 Nov; 31(6):403-11. PubMed ID: 8762565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UVEAL EFFUSION SYNDROME. CASE REPORT.
    Konrád A; Penčák M; Veith M; Studený P
    Cesk Slov Oftalmol; 2021; 77(4):202-206. PubMed ID: 34507496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uveal effusion in Hunter's syndrome. Evidence that abnormal sclera is responsible for the uveal effusion syndrome.
    Vine AK
    Retina; 1986; 6(1):57-60. PubMed ID: 3085183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical presentation and treatment outcomes of an algorithmic approach to uveal effusion syndrome.
    Desai A; Parameswarappa DC; Senthil S; Jayanna S; Pappuru RR; Jalali S; Rani PK
    Indian J Ophthalmol; 2022 Dec; 70(12):4349-4356. PubMed ID: 36453343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified ultrasound-guided surgical technique for the management of the uveal effusion syndrome in patients with normal axial length and scleral thickness.
    Ghazi NG; Richards CP; Abazari A
    Retina; 2013 Jun; 33(6):1211-9. PubMed ID: 23503341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Nanophthalmos-Related Uveal Effusion with Two- vs. Four-Quadrant Partial-Thickness Sclerectomy and Sclerotomy Surgery.
    Özdek Ş; Yalınbaş Yeter D; Özmen MC; Hasanreisoğlu M
    Turk J Ophthalmol; 2022 Feb; 52(1):37-44. PubMed ID: 35196838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.